- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
United Therapeutics Corp+ Add to Watchlist
UTHR:US69.1700 USD 0.6900 1.01%
As of 20:10:00 ET on 05/17/2013.
Company Profile for United Therapeutics Corp (UTHR)
United Therapeutics Corporation develops pharmaceuticals to treat vascular diseases such as pulmonary hypertension and peripheral vascular disease. The Company's lead products are stable synthetic forms of prostacyclin and are delivered orally or subcutaneously. United's products are currently in Phase III clinical trials.
United Therapeutics Corp
Key Executives for United Therapeutics Corp (UTHR)
|Martine A RothblattChairman/CEO/Founder||Roger A JeffsPresident/COO|
|John M FerrariCFO/Treasurer||Paul A MahonExec VP/Secy/General Counsel|